venBio Select Advisor as of June 30, 2016
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 39 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 13.3 | $64M | 3.4M | 19.07 | |
| Tesaro | 8.9 | $43M | 514k | 84.05 | |
| Lion Biotechnologies | 7.3 | $35M | 4.3M | 8.10 | |
| Celator Pharmaceuticals | 7.0 | $34M | 1.1M | 30.18 | |
| BioMarin Pharmaceutical (BMRN) | 7.0 | $34M | 433k | 77.80 | |
| Bristol Myers Squibb (BMY) | 6.8 | $33M | 445k | 73.55 | |
| Neurocrine Biosciences (NBIX) | 4.8 | $23M | 509k | 45.45 | |
| Dermira | 4.4 | $21M | 722k | 29.25 | |
| Immunomedics | 4.3 | $21M | 9.0M | 2.32 | |
| Amicus Therapeutics (FOLD) | 4.2 | $20M | 3.7M | 5.46 | |
| Medivation | 3.5 | $17M | 280k | 60.30 | |
| Global Blood Therapeutics In | 3.3 | $16M | 964k | 16.59 | |
| Agenus | 2.6 | $13M | 3.1M | 4.05 | |
| Relypsa | 2.4 | $11M | 613k | 18.50 | |
| ACADIA Pharmaceuticals (ACAD) | 2.2 | $11M | 330k | 32.46 | |
| Sorrento Therapeutics (SRNE) | 1.9 | $9.3M | 1.7M | 5.60 | |
| Teligent | 1.9 | $9.2M | 1.3M | 7.14 | |
| Gilead Sciences (GILD) | 1.9 | $9.1M | 109k | 83.42 | |
| Neuroderm Ltd F | 1.9 | $9.1M | 557k | 16.25 | |
| Vanda Pharmaceuticals (VNDA) | 1.6 | $7.9M | 710k | 11.19 | |
| Mirati Therapeutics | 1.4 | $6.6M | 1.2M | 5.46 | |
| Cascadian Therapeutics | 1.1 | $5.4M | 5.7M | 0.94 | |
| Cytokinetics (CYTK) | 1.0 | $4.8M | 504k | 9.49 | |
| Veracyte (VCYT) | 1.0 | $4.6M | 919k | 5.03 | |
| Akebia Therapeutics (AKBA) | 1.0 | $4.7M | 622k | 7.48 | |
| Fortress Biotech | 0.7 | $3.6M | 1.3M | 2.69 | |
| Innocoll Hldgs | 0.5 | $2.6M | 468k | 5.51 | |
| Trillium Therapeutics, Inc. Cmn | 0.4 | $2.1M | 229k | 8.98 | |
| Oncobiologics | 0.3 | $1.6M | 467k | 3.40 | |
| Assembly Biosciences | 0.3 | $1.4M | 261k | 5.55 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.3 | $1.5M | 7.0M | 0.21 | |
| La Jolla Pharmaceuticl Com Par | 0.2 | $1.1M | 70k | 16.00 | |
| Cellectis S A (CLLS) | 0.2 | $1.1M | 43k | 26.60 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $1.1M | 75k | 14.26 | |
| Vericel (VCEL) | 0.1 | $574k | 255k | 2.25 | |
| Nantkwest | 0.1 | $450k | 72k | 6.21 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $107k | 233k | 0.46 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $105k | 233k | 0.45 | |
| Ishares Tr Index option | 0.0 | $19k | 50k | 0.38 |
